Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Member Zhenya Lindgardt as Interim President and CEO Engages Leading Strategy ...

Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy ...

SALT LAKE CITY, Nov. 22, 2023 /PRNewswire/ -- Sera Prognostics Inc. (SERA), The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy ...

The company reiterated plans to publish the PRIME study in a peer-reviewed journal by year-end and to host an investor and analyst event immediately following acceptance. Management expects a "steady ...

Amid another soft session on Wall Street, Sera Prognostics (NASDAQ:SERA) — a specialist in the field of maternal and neonatal health — shook up the market with a dramatic increase in value. Fueling ...

Ongoing progress in engaging Medicaid plans in targeted states with prior PreTRM clinical study experience. Notable traction in two particular states with above-average premature birth rates, ...

Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy ...

Live audio of the webcast will be available online from the Investors page of the Company's website at www.sera.com. The webcast will be archived on the Investors page and will be available for one ...

SALT LAKE CITY, Feb. 10, 2025 /PRNewswire/ — Sera Prognostics, Inc., The Pregnancy Company ® (“Sera” or the “Company”) (Nasdaq: SERA), which focuses on improving maternal and neonatal health by ...

Sera Prognostics, Inc. (SERA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

SALT LAKE CITY, March 19, 2025 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy ...

"Following the results of our full PRIME pivotal study being publicized we are leveraging them by engaging with key plan providers in focused geographic regions hard hit by premature birth," said ...